Leucine-rich repeat kinase 2 (LRRK2) is localized on lysosomes and... | Download Scientific Diagram
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease: Trends in Pharmacological Sciences
Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain - Civiero - 2015 - Journal of Neurochemistry - Wiley Online Library
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review | Journal of Biomedical Science | Full Text
Leucine-rich repeat kinase 2: Relevance to Parkinson's disease - ScienceDirect
Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 | PNAS
RCSB PDB - 2ZEJ: Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
PDF] Exploring the Role of Parkinson's-Linked Leucine-Rich Repeat Kinase-2 in the Immune System | Semantic Scholar
The Kinase domain of Leucine-Rich Repeat Kinase 2 (LRRK2). (A)... | Download Scientific Diagram
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease | Journal of Medicinal Chemistry
Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses - ScienceDirect
Leucine‐rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease - Cogo - 2020 - Journal of Neurochemistry - Wiley Online Library
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? | BMC Medicine | Full Text
Glucocerebrosidase 1 and leucine‐rich repeat kinase 2 in Parkinson disease and interplay between the two genes - Lee - 2021 - Journal of Neurochemistry - Wiley Online Library
The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports
LRRK2 - Wikipedia
Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease | Future Medicinal Chemistry